What to Expect From Clarivate’s Upcoming Q3 Results?
<p>RBC Capital analysts provided their outlook on <a href='https://financialmodelingprep.com/financial-summary/CLVT'>Clarivate (NYSE:CLVT)</a> ahead of the upcoming Q3/22 earnings, trimming their H2/22 and fiscal 2023 estimates to account for incremental FX headwinds, higher interest expense, and a more cautious view on transactional revenues, given the potential economic slowdown.</p>
<p>Accordingly, the analysts lowered their 2022/2023 EPS estimates to $0.80/$0.83, below the Street estimates of $0.85/ $0.95, and reduced their price target to $13 from $16. </p>
<p>Although the company lowered organic growth for Q3/22 to approximately 3%, the analysts believe the company should also de-risk organic growth expectations for Q4/22 and 2023 in light of the challenging macro environment.</p>

NYSE:CLVT